Kuhn Rebecca 4
4 · NeuroPace Inc · Filed Mar 20, 2025
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Kuhn Rebecca
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2025-03-10+11,700→ 136,595 total - Award
Stock Option (Rt to Buy)
2025-03-10+19,850→ 19,850 totalExercise: $10.04Exp: 2035-03-09→ Common Stock (19,850 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2026 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
- [F2]25% of the shares subject to the option vest on March 3, 2026. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.